作者: Soo-Sang Kang , Paul W. K. Wong , Paul B. Glickman , Catherine M. MacLeod , Israeli A. Jaffe
DOI: 10.1002/J.1552-4604.1986.TB02978.X
关键词:
摘要: Protein-bound homocyst(e)ine was measured in the plasma of 38 nonhomocystinuric patients with rheumatoid arthritis. Nineteen them were treated orally D-penicillamine 100-1,500 mg/d for a period one month to 15 years. For these patients, mean +/- standard deviation level protein-bound 1.95 1.07 nmol/mL. In contrast, 4.72 1.11 nmol/mL 19 who had not been oral D-penicillamine. There statistically significant difference (P less than .0001) concentrations between and without therapy. Thus, it may be speculated that beneficial protecting from development thromboembolism arteriosclerosis.